A randomized, placebo-controlled pilot study of patients with spontaneous intraventricular haemorrhage treated with intraventricular thrombolysis

Abstract Intraventricular hemorrhage (IVH) occurring after spontaneous intracerebral hemorrhage (ICH) is an independent risk factor for mortality. The use of intraventricular urokinase (Uk) to reduce intraventricular blood clot volume and improve outcome was investigated. Patients with IVH requiring...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of clinical neuroscience 2012-07, Vol.19 (7), p.961-964
Hauptverfasser:	King, Nicolas K.K, Lai, Jin Li, Tan, Li Bing, Lee, Kah Keow, Pang, Boon Chuan, Ng, Ivan, Wang, Ernest
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Analysis of Variance Blood clot Blood coagulation Cerebral Hemorrhage - cerebrospinal fluid Cerebral Hemorrhage - diagnostic imaging Cerebral Hemorrhage - drug therapy Cerebral Hemorrhage - mortality Cerebrospinal fluid Clinical trials Computed tomography Double-Blind Method Drainage External ventricular drainage Female Fibrinolytic Agents - therapeutic use Hemoglobin Hemoglobins - cerebrospinal fluid Hemorrhage Humans Infection Injections, Intraventricular Intensive care units Intraventricular hemorrhage Kaplan-Meier Estimate Male Middle Aged Mortality Nervous system Neurology Pilot Projects Risk factors Severity of Illness Index Statistics, Nonparametric Stroke Survival Thrombolysis Time Factors Tomography, X-Ray Computed Treatment Outcome u-Plasminogen activator Urokinase Urokinase-Type Plasminogen Activator - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!